(A) The expression of NR2F1 (a, d, g, j, m) and NR2F2 (b, e, h, k, n) in coronal sections (a–f) and sagittal sections (g–o) of the hippocampus at postnatal month 1 (1M); representative western blots …
The Nissl staining results of the control and RXCre/+; Nr2f2F/F mutant mice at 1M (part 1); the expression of HuB and Ctip2 in the hippocampus of the control and RXCre/+; Nr2f2F/F mutant mice at 1M (part 1).
The expression of NR2F1 and NR2F2 in coronal sections and sagittal sections of the mouse brain at 1M (part 1); the expression of HuB and Ctip2 in the hippocampus of the control and RXCre/+; Nr2f2F/F mutant mice at 1M (part 2).
The expression of NR2F1 and NR2F2 in coronal sections and sagittal sections of the mouse brain at 1M (part 2).
The expression of NR2F1 and NR2F2 in sagittal sections of the mouse brain at 1M (part 1).
The expression of NR2F1 and NR2F2 in sagittal sections of the mouse brain at 1M (part 2); the Nissl staining results of the control and RXCre/+; Nr2f2F/F mutant mice at 1M (part 2).
The expression of NR2F1 and NR2F2 in sagittal sections of the mouse brain at 1M (part 3); western blots data for the expression of NR2F1 and NR2F2 in the dorsal and ventral hippocampus at 1M; the Nissl staining results of the control and RXCre/+; Nr2f2F/F mutant mice at 1M (part 3).
(A) The expression of Nr2f1 and Nr2f2 genes in the forebrain at E10.5 (a, b) and E11.5 (c, d). (B) The expression of Nr2f1 and Nr2f2 genes in the developing hippocampus at E12.5 (a–c), E14.5 (d–f), …
The expression of Nr2f1 and Nr2f2 genes in the developing hippocampus at E12.5; the deletion efficiency of RXCre recombinase in the hippocampus of RXCre/+; Nr2f2F/F, RXCre/+; Nr2f1F/F, and RXCre/+; Nr2f1F/F; Nr2f2F/F mice (part 1).
The expression of Nr2f1 and Nr2f2 genes in the telencephalon at E10.5, E11.5, E14.5, and P0; the deletion efficiency of RXCre recombinase in the hippocampus of RXCre/+; Nr2f2F/F, RXCre/+; Nr2f1F/F, and RXCre/+; Nr2f1F/F; Nr2f2F/F mice (part 2).
(A) In coronal sections along the rostrocaudal axis (a–f) and sagittal sections along the lateral–medial axis (g–l) of the hippocampus, compared with that of control mice (a–c, g–i), the dorsal …
The Nissl staining results of the control and RXCre/+; Nr2f1F/F mutant mice at 1M (part 1).
The Nissl staining results of the control and RXCre/+; Nr2f1F/F mutant mice at 1M (part 2); the expression of HuB and Wfs1 in the hippocampus of the control and RXCre/+; Nr2f1F/F mutant mice at 1M.
The expression of HuB and Ctip2 in the hippocampus of the control and RXCre/+; Nr2f1F/F mutant mice at 1M.
The expression of HuB, Wfs1, and Ctip2 in the hippocampus of the control and RXCre/+; Nr2f1F/F mutant mice at 1M.
(A) Immunofluorescence staining data showed that compared with those of control mice (a, c, e, g), the proportions of either the Wfs1- or Ctip2-positive dorsal CA1 domain were reduced in Emx1Cre/+; …
The expression of Wfs1 and Ctip2 in the dorsal hippocampus of the control and Emx1Cre/+; Nr2f1F/F mutant mice at 3M; Golgi staining results of the dorsal hippocampal CA1 pyramidal neurons and Morris water maze behavior test data of the control and Emx1Cre/+; Nr2f1F/F mutant mice.
(A) In coronal sections along the rostrocaudal axis, compared with control mice (a–d), the hippocampus was atrophic in RXCre/+; Nr2f1F/F; Nr2f2F/F double-mutant mice, indicated by the star, and an …
The Nissl staining results of the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-gene mutant mice at 3W.
The expression of HuB and Ctip2 in the hippocampus of the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-gene mutant mice at 3W.
The expression of HuB and Prox1 in the hippocampus of the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-gene mutant mice at 3W.
The expression of HuB, Ctip2, and Prox1 in the hippocampus of the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-gene mutant mice at 3W.
(A) The expression of GFAP and Nestin, markers of NSCs, in the SGZ of the vDG in control and Nr2f2 mutant mice at 1M (a–h), in the SGZ of the dDG in control and Nr2f1 mutant mice at 1M (i–p) and in …
The expression of GFAP, Nestin, and Dcx in the subgranular zone (SGZ) of ventral dentate gyrus (vDG) in the control and RXCre/+; Nr2f2F/F mutant mice at 1M, in the SGZ of dorsal dentate gyrus (dDG) in the control and RXCre/+; Nr2f1F/F mutant mice at 1M, and in the SGZ of DG in the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-gene mutant mice at 3W (part 1).
The expression of GFAP, Nestin, and Dcx in the subgranular zone (SGZ) of ventral dentate gyrus (vDG) in the control and RXCre/+; Nr2f2F/F mutant mice at 1M, in the SGZ of dorsal dentate gyrus (dDG) in the control and RXCre/+; Nr2f1F/F mutant mice at 1M, and in the SGZ of DG in the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-gene mutant mice at 3W (part 2).
The expression of GFAP and Nestin in the subgranular zone (SGZ) of ventral dentate gyrus (vDG) in the control and RXCre/+; Nr2f2F/F mutant mice at 1M, in the SGZ of dorsal dentate gyrus (dDG) in the control and RXCre/+; Nr2f1F/F mutant mice at 1M, and in the SGZ of DG in the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-gene mutant mice at 3W; quantitative analysis of GFAP/Nestin-positive cells in the SGZ of DG in the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-gene mutant mice at 3W.
The expression of GFAP, Nestin, and Dcx in the subgranular zone (SGZ) of ventral dentate gyrus (vDG) in the control and RXCre/+; Nr2f2F/F mutant mice at 1M, in the SGZ of dorsal dentate gyrus (dDG) in the control and RXCre/+; Nr2f1F/F mutant mice at 1M, and in the SGZ of DG in the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-gene mutant mice at 3W (part 3); quantitative analysis of Dcx-positive cells in the SGZ of DG in the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-gene mutant mice at 3W.
(A) The expression of Calretinin, Calbindin, and SMI312 in the ventral hippocampus of the control (a, b, e, f, i, j) and Nr2f2 single-gene mutant mice (c, d, g, h, k, l). (B) The expression of …
The expression of Calretinin, Calbindin, and SMI312 in the ventral hippocampus of the control and RXCre/+; Nr2f2F/F single-gene mutant mice at 1M.
The expression SMI312 in the dorsal hippocampus of the control and RXCre/+; Nr2f1F/F single-gene mutant mice at 1M, and the expression of Calretinin and Calbindin in the hippocampus of the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-gene mutant mice at 3W.
The expression of Calretinin and Calbindin in the dorsal hippocampus of the control and RXCre/+; Nr2f1F/F single-gene mutant mice at 1M, and the expression of SMI312 in the hippocampus of the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-gene mutant mice at 3W.
(A) The expression profiles of genes involved in hippocampal development in control and the double-mutant mice at E11.5. Data are presented as mean ± SEM. Student’s t test was used in A, *P<0.05, **P…
The expression of Lhx5 and Lhx2 in the telencephalon of the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-mutant mice at E14.5; the expression of Tbr2 and NeuroD1 in the telencephalon of the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-mutant mice at E14.5 (part 1).
The expression of Sox2, Tbr2, and NeuroD1 in the telencephalon of the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-mutant mice at E14.5.
The expression profiles of genes involved in the hippocampal development of the control and double-mutant mice at E11.5; the expression of Lhx5 and Lhx2 in the telencephalon of the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-mutant mice at E11.5 and E13.5; the expression of Tbr2 and NeuroD1 in the telencephalon of the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-mutant mice at E14.5 (part 2); quantitative analysis of Tbr2-positive and NeuroD1-positive cells in the hippocampal primordium of the control and RXCre/+; Nr2f1F/F; Nr2f2F/F double-mutant mice at E14.5.
Roles of Nr2f1 and Nr2f2 genes in the development and function of the hippocampus and the association with neurological diseases. Nr2f1 is required for the morphogenesis of the dorsal hippocampus …
Roles of Nr2f1 and Nr2f2 genes in the development and function of the hippocampus and the association with neurological disorders.